# Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation

> **NCT01734447** · PHASE4 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 57 (actual)

## Conditions studied

- Foetal Growth Problem
- Small for Gestational Age

## Interventions

- **DRUG:** somatropin
- **DRUG:** somatropin
- **DRUG:** somatropin

## Key facts

- **NCT ID:** NCT01734447
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-04-30
- **Primary completion:** 2003-04-30
- **Final completion:** 2003-04-30
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2017-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01734447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01734447, "Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT01734447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*